Benjamin Halladay - Insider Trading & Ownership

Entity
Individual
Location
Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Summary
The estimated net worth of Benjamin Halladay is at least $448K dollars as of February 20, 2025. Benjamin Halladay is the Chief Financial Officer of Esperion Therapeutics, Inc. and owns shares of Esperion Therapeutics, Inc. (ESPR) stock worth about $448K.
All Insider Reports
All Insider Reports

Ownership of Benjamin Halladay

Insider Transactions Reported by Benjamin Halladay:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.